Evidence map›Paper›PMID 28106081›Full record

ArticleScientific reports2017

Shigatoxin encoding Bacteriophage ϕ24

G S Holt, J K Lodge, A J McCarthy, A K Graham, G Young, S H Bridge, A K Brown, M Veses-Garcia, C V Lanyon, A Sails and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Molecular Modeling the Proteins from theAntibiotics (Basel, Switzerland) · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

G S HoltFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
J K LodgeFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
A J McCarthyMicrobiology Research Group, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
A K GrahamFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
G YoungFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
S H BridgeFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
A K BrownSchool of Medicine, Pharmacy and Health, Durham University, Durham, UK.
M Veses-GarciaMicrobiology Research Group, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
C V LanyonFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
A SailsPublic Health England, Royal Victoria Hospital, Newcastle upon Tyne, UK.
H E AllisonMicrobiology Research Group, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
D L SmithFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Northumbria University · GBUniversity of Liverpool · GBDurham University · GBRoyal Victoria Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

How temperate bacteriophages play a role in microbial infection and disease progression is not fully understood. They do this in part by carrying genes that promote positive evolutionary selection for the lysogen. Using Biolog phenotype microarrays and comparative metabolite profiling we demonstrate the impact of the well-characterised Shiga toxin-prophage ϕ24

Indexed as

Anti-Bacterial AgentsArea Under CurveBacteriophagesCell ProliferationDiscriminant AnalysisEscherichia coliKanamycin ResistanceLysogenyMetabolomicsMultivariate AnalysisOsmotic PressureOxyquinolineShiga ToxinXylenesAnti-Bacterial AgentschloroxylenolOxyquinolineShiga ToxinXylenes

Identifiers

PMID28106081
PMCPMC5247750
OpenAlexW2576007987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.